Global Cancer Pain Market Report 2022: Industry set to Grow by 5.71% Annually Through 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cancer Pain Market Analysis by Disease Indication, by Drug Type, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The cancer pain market size is estimated to be USD 6,599.12 million in 2021 and is expected to witness a CAGR of 5.71% during the forecast period 2022-2029. The ageing population, rising cancer prevalence, rising healthcare costs, and rising R&D spending by various healthcare businesses are projected to drive the market growth in near future. However, side effects like medication tolerance, drug dependence, urine retention, sleep problems, cognitive impairment, and others are expected to restrain the market growth.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including disease indication and drug type from 2021 to 2029.

Segmentation: Cancer Pain Market Report 2021-2029Disease Indication (Revenue, USD Million)

• Colorectal Cancer
• Blood Cancer
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Others

Drug Type (Revenue, USD Million)

• Non-Opioids
• Opioids
• Nerve Blockers

By Region (Revenue, USD Million)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Cancer Pain

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Cancer Pain Market

7. Market Analysis by Disease Indication

8. Market Analysis by Drug Type

9. Regional Market Analysis

10. North America Cancer Pain Market

11. Europe Cancer Pain Market

12. Asia Pacific Cancer Pain Market

13. Latin America Cancer Pain Market

14. MEA Cancer Pain Market

15. Competitor Analysis

16. Company Profiles

17. Conclusion & Recommendations

Companies Mentioned

• Mundipharma International Limited
• Biodelivery Sciences International Inc.
• Aoxing Pharmaceutical Company Inc.
• Ck Life Sciences (Wex Pharmaceuticals).
• Daiichi Sankyo Co. Ltd.
• Hisamitsu Pharmaceutical Co. Inc.
• Orexo Ab
• Pfizer Inc.
• Grunenthal Pharma Gmbh & Co. Kg
• Teva Pharmaceutical Industries Limited.

For more information about this report visit https://www.researchandmarkets.com/r/pdfrxn

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900